These genes (JCHAIN and CD79A) were reported to be lower expressed altogether in colorectal carcinoma and in others non-squamous cell carcinoma by Pan J. et al. (2021), suggesting a potential indicator for immunotherapy. Here, CD79A is linked to colorectal carcinoma.